Related Experiment Videos
The implantable cardioverter defibrillator
1Cardiology Department, Royal Devon and Exeter Hospital, Exeter EX2 5DW.
Hospital Medicine (London, England : 1998)
|December 12, 2002
Insights
The implantable cardioverter defibrillator (ICD) is the best treatment for preventing sudden cardiac death in high-risk patients. This review covers the evidence and guidelines for ICD implantation.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Sudden cardiac death (SCD) remains a significant cause of mortality.
- Life-threatening cardiac arrhythmias necessitate effective preventative strategies.
Purpose of the Study:
- To review the established indications for implantable cardioverter defibrillator (ICD) use.
- To summarize the supporting evidence for ICD therapy in preventing SCD.
Main Methods:
- Literature review of clinical trials and guidelines.
- Analysis of patient populations benefiting from ICDs.
Main Results:
- ICDs are indicated for primary and secondary prevention of SCD.
- Strong evidence supports ICD use in patients with documented ventricular arrhythmias or high-risk conditions.
Conclusions:
- Implantable cardioverter defibrillators are crucial for managing patients at risk of sudden cardiac death.
- Adherence to guidelines ensures optimal patient selection for ICD therapy.
Abstract:
The implantable cardioverter defibrillator is the optimal treatment for both primary and secondary prevention in patients with previous aborted sudden death and with life-threatening cardiac arrhythmias. This article will review the indications and the evidence supporting implantable cardioverter defibrillator use.